Prediction of the volume of large prostate cancers by multiple core biopsies

References

• McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 1990; 66: 1225–33
   PubMed Web of Science ®Google Scholar
• McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 1992; 23: 258–66
   PubMed Web of Science ®Google Scholar
• Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999; 281: 1395–400
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Graham S, Jr, Napalkov P, Abrahamsson PA, di-Sant'agnese PA, Algaba F, et al. Staging of early prostate cancer: a proposed tumor volume-based prognostic index”. Urology 1993; 41: 403–11
   PubMed Web of Science ®Google Scholar
• Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 1993; 149: 1478–81
   PubMed Web of Science ®Google Scholar
• Humphrey PA, Walther PJ, Currin SM, Vollmer RT. Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison. Am J Surg Pathol 1991; 15: 1165–70
   PubMed Web of Science ®Google Scholar
• Lerner SE, Blute ML, Zincke H. Risk factors for progression in patients with prostate cancer treated with radical prostatectomy. Semin Urol Oncol 1996; 14: 12–20
   PubMedGoogle Scholar
• Terris MK, Haney DJ, Johnstone IM, McNeal JE, Stamey TA. Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology 1995; 45: 75–80
   PubMed Web of Science ®Google Scholar
• Peller PA, Young DC, Marmaduke DP, Marsh WL, Badalament RA. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer 1995; 75: 530–8
   PubMed Web of Science ®Google Scholar
• Noguchi, M, Stamey, TA, McNeal, JE, Yemoto, CM. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol 2001;166:104–9; discussion 9–10.
   PubMed Web of Science ®Google Scholar
• Egevad L, Norberg M, Mattson S, Norlen BJ, Busch C. Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy. Urology 1998; 52: 653–8
   PubMed Web of Science ®Google Scholar
• Cupp MR, Bostwick DG, Myers RP, Oesterling JE. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis [see comments]. J Urol 1995; 153: 1543–8
   PubMed Web of Science ®Google Scholar
• Terris MK, McNeal JE, Stamey TA. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. J Urol 1992; 148: 829–32
   PubMed Web of Science ®Google Scholar
• Weldon VE, Tavel FR, Neuwirth H, Cohen R. Failure of focal prostate cancer on biopsy to predict focal prostate cancer: the importance of prevalence. J Urol 1995; 154: 1074–7
   PubMed Web of Science ®Google Scholar
• Wang X, Brannigan RE, Rademaker AW, McVary KT, Oyasu R. One core positive prostate biopsy is a poor predictor of cancer volume in the radical prostatectomy specimen. J Urol 1997; 158: 1431–5
   PubMed Web of Science ®Google Scholar
• Thorson P, Vollmer RT, Arcangeli C, Keetch DW, Humphrey PA. Minimal carcinoma in prostate needle biopsy specimens—diagnostic features and radical prostatectomy follow-up. Mod Pathol 1998; 11: 543–51
   PubMed Web of Science ®Google Scholar
• Dietrick DD, McNeal JE, Stamey TA. Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volume. Urology 1995; 45: 987–92
   PubMed Web of Science ®Google Scholar
• Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC. Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 1989; 141: 341–5
   PubMed Web of Science ®Google Scholar
• Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. J Urol 2004; 172: 508–11
   PubMed Web of Science ®Google Scholar
• Norberg M, Holmberg L, Wheeler T, Magnusson A. Five year follow-up after radical prostatectomy for localized prostate cancer—a study of the impact of different tumor variables on progression. Scand J Urol Nephrol 1994; 28: 391–9
   PubMed Web of Science ®Google Scholar
• Freedland SJ, Aronson WJ, Csathy GS, Kane CJ, Amling CL, Presti JC, Jr, et al. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Urology 2003; 61: 742–7
   PubMed Web of Science ®Google Scholar